Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

WILL-GRUNDY MEDICAL CLINIC, INC.

UEI: NR9SE8RPR4N6CAGE: 91LQ1

WILL-GRUNDY MEDICAL CLINIC, INC. is a federal contractor, registered under UEI NR9SE8RPR4N6 and CAGE code 91LQ1. It has been awarded $2,168,206 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Housing And Urban Development (hud), Department Of Housing And Urban Development, and Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

NR9SE8RPR4N6

CAGE Code

91LQ1

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

621498All Other Outpatient Care Centers(Primary)
621999All Other Miscellaneous Ambulatory Health Care Services

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

WILL-GRUNDY MEDICAL CLINIC LTD provides outpatient medical services under NAICS 621498, which encompasses other outpatient care centers, typically including specialized clinical operations such as diagnostic testing, preventive health screenings, and chronic disease management. The firm delivers pri...

WILL-GRUNDY MEDICAL CLINIC LTD provides outpatient medical services under NAICS 621498, which encompasses other outpatient care centers, typically including specialized clinical operations such as diagnostic testing, preventive health screenings, and chronic disease management. The firm delivers primary and specialty outpatient care in a community-based setting, with a focus on patient-centered clinical workflows, electronic health record integration, and compliance with HIPAA and CMS billing standards. Their operational model emphasizes efficient care coordination, point-of-service diagnostics, and adherence to quality metrics for ambulatory care delivery. While no specific award history is available to infer contract-based performance, the entity’s classification suggests a direct clinical service delivery capability rather than a systems integration or IT support function. No agency relationships can be identified due to absence of award data, and there is no evidence of engagement with federal procurement programs. The business operates as a small, privately held entity under the 8H classification, indicating it is a small business owned and controlled by individuals. It holds no government-recognized certifications such as 8(a), HUBZone, or WOSB. Located in Joliet, IL, the organization serves the local healthcare market with a focus on outpatient clinical excellence, positioning itself within the regional network of community health providers rather than as a federal contractor. Its market presence is grounded in direct patient care delivery rather than government contracting or large-scale service procurement.

Key Performance Metrics

Awards Count

14

All time

Active

0

Currently performing

Completed

14

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
- Unknown NAICS$2.1M100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with WILL-GRUNDY MEDICAL CLINIC, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for WILL-GRUNDY MEDICAL CLINIC, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in WILL-GRUNDY MEDICAL CLINIC, INC.'s top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding for U.S. small business concerns (SBCs) to conduct research and development of commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants must be for-profit entities located in the U.S., owned more than 50 percent by U.S. citizens or permanent residents, and employ no more than 500 people. The program accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being NIH-specific options to accelerate development. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on an overall impact score, considering commercial potential, technical feasibility, and the quality of the commercialization plan. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines; notably, several institutes, including NIAID and NIAMS, do not accept clinical trials under this NOFO. Applicants must maintain active registrations in SAM, possess a Unique Entity Identifier, and comply with cybersecurity incident reporting requirements, including notifying HHS within 48 hours of a discovery.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the project toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being specific to the NIH. Budget limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the environment for success. While clinical trials are generally optional, they are prohibited for specific components, including all FDA centers and several NIH institutes such as NIAMS and NIDCR. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. All applications must be submitted electronically, with a final expiration date of April 06, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage research and development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including technical assistance for regulatory and intellectual property strategies, manufacturing scale-up, independent replication of key studies, and clinical trials. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible applicants must be for-profit organizations with no more than 500 employees and maintain active registrations in the System for Award Management and the SBA Company Registry. Project periods are limited to a maximum of three years, with budget ceilings varying by participating Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via NIH peer review based on scientific and technical merit, commercial potential, and relevance to program priorities. Key submission requirements include a detailed regulatory plan and a CRP progress report, while costs for patent or FDA filing fees and separate Technical and Business Assistance funding are strictly prohibited.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details